Skip to main content
FDA fast-tracks review of Cerecor's drug for rare metabolic disorder
8/22/2019

Cerecor's application for CERC-802, indicated for the treatment of mannose-phosphate isomerase deficiency, a rare inherited metabolic disorder, was granted Fast Track status by the FDA.

Full Story: